Exact Mass: 318.0103
Exact Mass Matches: 318.0103
Found 38 metabolites which its exact mass value is equals to given mass value 318.0103,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol
(5E)-2-amino-5-[(6-bromo-1H-indol-3-yl)methylidene]-3-methylimidazol-4-one
3-(3,3-Dichloro-2-hydroxypropyl)-6-methoxy-8-hydroxy-1H-2-benzopyran-1-one
1-Methyl-2-amino-5-(6-bromo-1H-indole-3-ylmethylene)-2-imidazoline-4-one
5,6-Dichlorobenzimidazole riboside
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.751 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.745 5,6-Dichlorobenzimidazole riboside (DRB) is a nucleoside analog that inhibits several carboxyl-terminal domain kinases, including casein kinase II and cell cycle-dependent kinases (CDK). 5, 6-dichlorobenzimidazole riboside has antitumor activity. 5, 6-dichlorobenzimidazole riboside can induce apoptosis[1][2][3][4][5][6][7].
DRB
5,6-Dichlorobenzimidazole riboside (DRB) is a nucleoside analog that inhibits several carboxyl-terminal domain kinases, including casein kinase II and cell cycle-dependent kinases (CDK). 5, 6-dichlorobenzimidazole riboside has antitumor activity. 5, 6-dichlorobenzimidazole riboside can induce apoptosis[1][2][3][4][5][6][7].
Bis(2,2,2-trifluoroethyl) (methoxycarbonylmethyl)phosphonate
2-(4-nitrophenoxy)-3-chloro-5-trifluoromethyl pyridine
tert-butyl N-(5-bromo-4-cyclopropyl-1,3-thiazol-2-yl)carbamate
4-BROMO-1,2-DIMETHYL-5-(QUINOXALIN-6-YL)-1H-PYRAZOL-3(2H)-ONE
4-(4-(thiophen-2-yl)thiazol-2-ylamino)-2-hydroxybenzoic acid
tert-Butyl 2-bromo-6,7-dihydrothiazolo[5,4-c]pyridine-5(4H)-carboxylate
Dichlororibofuranosylbenzimidazole
D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors 5,6-Dichlorobenzimidazole riboside (DRB) is a nucleoside analog that inhibits several carboxyl-terminal domain kinases, including casein kinase II and cell cycle-dependent kinases (CDK). 5, 6-dichlorobenzimidazole riboside has antitumor activity. 5, 6-dichlorobenzimidazole riboside can induce apoptosis[1][2][3][4][5][6][7].
